Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Harraden Circle Investments, LLC BCARU D. Boral ARC Acquisition I Corp. 13G/A 9.06% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ VRRM VERRA MOBILITY Corp 13G/A 0.2% 3mo
COHEN & STEERS, INC. ADC Agree Realty Corp 13G/A 13.71% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ ST Sensata Technologies Holding plc 13G/A 6.6% 3mo
AMERIPRISE FINANCIAL INC HBB Hamilton Beach Brands Holding Co 13G/A 5.4% 3mo
Davidson Kempner Capital Management LP NUAI New ERA Energy & Digital, Inc. 13G/A 0.37% 3mo
G1 Execution Services, LLC HUCK Huckleberry.ai, Inc. 13G 5.2% 3mo
Sirenia Capital Management LP TRAX First Tracks Biotherapeutics, Inc. 13G 7.2% 3mo
GMT Capital Corp CINT CI&T Inc 13G/A 1.2% 3mo
Lytton, Laurence W. AYTU Aytu Biopharma, Inc 13G/A 4.99% 3mo
Philosophy Capital Management LLC NINE Nine Energy Service, Inc. 13G/A 17% 3mo
Nantahala Capital Management, LLC IMUX Immunic, Inc. 13G/A 7.47% 3mo
Trails Edge Capital Partners, LP NGNE Neurogene Inc. 13G/A 4.5% 3mo
Tao Yang YALA Yalla Group Ltd 13G/A 43.2% 3mo
Davidson Kempner Capital Management LP NVRI Enviri Corp 13G/A 0% 3mo
SUVRETTA CAPITAL MANAGEMENT, LLC ABEO Abeona Therapeutics Inc. 13G/A 0.9% 3mo
Bellevue Group AG JBIO Jade Biosciences, Inc. 13G/A 5% 3mo
J. Goldman & Co LP DXYZ Destiny Tech100 Inc. 13G 5.57% 3mo
Alger Associates, Inc. 13-3017981 ALAI Alger ETF Trust 13G/A 8.3% 3mo
TANG CAPITAL MANAGEMENT LLC CAPR Capricor Therapeutics, Inc. 13G/A 7.1% 3mo
ARISTEIA CAPITAL, L.L.C. TMS Teamshares Inc 13G/A 0% 3mo
Gallatin Point Capital LLC FRBT Forbright, Inc. 13G 9.9% 3mo
CB Elevate Aggregator L.P. FRBT Forbright, Inc. 13G 9.9% 3mo
ADAR1 Capital Management, LLC ADGM Adagio Medical Holdings, Inc. 13G/A 5.4% 3mo
Situational Awareness LP SHAZ SharonAI Holdings Inc. 13G/A 19.9% 3mo
American Century Investment Management, Inc. KE Kimball Electronics, Inc. 13G 5.4% 3mo
Redmile Group, LLC NRIX Nurix Therapeutics, Inc. 13G/A 8.1% 3mo
Durable Capital Partners LP FOUR Shift4 Payments, Inc. 13G/A 5.6% 3mo
Manulife Investment Management (US) LLC FWRG First Watch Restaurant Group, Inc. 13G/A 6.18% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ WOLF Wolfspeed, Inc. 13G/A 11.1% 3mo
ALLIANCEBERNSTEIN L.P. CELH Celsius Holdings, Inc. 13G/A 3.3% 3mo
Austin Meyer BETA BETA Technologies, Inc. 13G/A 5.4% 3mo
ARMISTICE CAPITAL, LLC AUTL Autolus Therapeutics plc 13G/A 5.64% 3mo
American Century Investment Management, Inc. CODI Compass Diversified Holdings 13G/A 5.4% 3mo
EVENTIDE ASSET MANAGEMENT, LLC IMMX Immix Biopharma, Inc. 13G 5.6% 3mo
AMERIPRISE FINANCIAL INC BILL BILL Holdings, Inc. 13G 5.6% 3mo
FRONTIER CAPITAL MANAGEMENT CO LLC BETR Better Home & Finance Holding Co 13G/A 4.78% 3mo
Gates Capital Management, Inc. MBC MasterBrand, Inc. 13G/A 6.5% 3mo
William A. Ackman PS Pershing Square Inc. 13G 45.3% 3mo
ARMISTICE CAPITAL, LLC CODX Co-Diagnostics, Inc. 13G 9.99% 3mo
American Century Investment Management, Inc. CBT Cabot Corp 13G 5.4% 3mo
James B. Tananbaum CGON CG Oncology, Inc. 13G/A 4.9% 3mo
PERCEPTIVE ADVISORS LLC ENGN enGene Therapeutics Inc. 13G/A 9.99% 3mo
Orbis Investment Management Limited NCMI National CineMedia, Inc. 13G/A 9.8% 3mo
BCLS Fund III Investments, LP HTFL Heartflow, Inc. 13G/A 9.8% 3mo
ADAR1 Capital Management, LLC RNTX Rein Therapeutics, Inc. 13G 5.3% 3mo
Millennium Management LLC SHAZ SharonAI Holdings Inc. 13G/A 4.8% 3mo
ARMISTICE CAPITAL, LLC RIGL Rigel Pharmaceuticals Inc 13G/A 8.95% 3mo
Zachary Bogue ("Bogue") FRVO Fervo Energy Co 13G 6.3% 3mo
VAN ECK ASSOCIATES CORP SKE Skeena Resources Ltd 13G/A 7.2% 3mo